The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment.

The HAS-BLED score enables a risk estimate of major bleeds in patients with atrial fibrillation on vitamin K-antagonists (VKA) treatment, but has not been validated for patients with venous thromboembolism (VTE). We analyzed whether the HAS-BLED score accurately identifies patients at high risk of m...

Full description

Bibliographic Details
Main Authors: Judith Kooiman, Nadja van Hagen, Antonio Iglesias Del Sol, Erwin V Planken, Gregory Y H Lip, Felix J M van der Meer, Suzanne C Cannegieter, Frederikus A Klok, Menno V Huisman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4407886?pdf=render

Internet

http://europepmc.org/articles/PMC4407886?pdf=render

Similar Items